Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Other Working Capital Changes (2016 - 2025)

Fennec Pharmaceuticals filings provide 15 years of Other Working Capital Changes readings, the most recent being $1.4 million for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes rose 296.8% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 259.17% increase, with the full-year FY2025 number at $1.3 million, up 259.17% from a year prior.
  • Other Working Capital Changes hit $1.4 million in Q4 2025 for Fennec Pharmaceuticals, up from -$520000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $25.1 million in Q2 2024 to a low of -$25.4 million in Q3 2024.
  • Median Other Working Capital Changes over the past 5 years was -$2000.0 (2025), compared with a mean of $86000.0.
  • The widest YoY moves for Other Working Capital Changes: up 13898.35% in 2024, down 11973.81% in 2024.
  • Fennec Pharmaceuticals' Other Working Capital Changes stood at $823000.0 in 2021, then crashed by 40.22% to $492000.0 in 2022, then increased by 5.69% to $520000.0 in 2023, then tumbled by 232.12% to -$687000.0 in 2024, then surged by 296.8% to $1.4 million in 2025.
  • The last three reported values for Other Working Capital Changes were $1.4 million (Q4 2025), -$520000.0 (Q3 2025), and $437000.0 (Q2 2025) per Business Quant data.